WallStreetZenWallStreetZen

NASDAQ: ACGN
Aceragen Inc Stock

$5.65+0.71 (+14.37%)
Updated Feb 3, 2023
ACGN Price
$5.65
Fair Value Price
N/A
Market Cap
$20.72M
52 Week Low
$3.66
52 Week High
$16.00
P/E
-0.9x
P/B
1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$16.22M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
2.59
Operating Cash Flow
-$15M
Beta
1.01
Next Earnings
Mar 29, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ACGN Overview

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACGN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACGN is good value based on its book value relative to its share price (1x), compared to the US Biotechnology industry average (5.11x)
P/B vs Industry Valuation
ACGN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ACGN due diligence checks available for Premium users.

Be the first to know about important ACGN news, forecast changes, insider trades & much more!

ACGN News

Valuation

ACGN fair value

Fair Value of ACGN stock based on Discounted Cash Flow (DCF)
Price
$5.65
Fair Value
$0.93
Overvalued by
508.93%
ACGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACGN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.9x
Industry
10.7x
Market
15.09x

ACGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1x
Industry
5.11x
ACGN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACGN's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.1M
Profit Margin
0%
ACGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$103.7M
Liabilities
$53.7M
Debt to equity
2.59
ACGN's short-term assets ($30.07M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACGN's long-term liabilities ($34.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACGN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.2M
Investing
$5.5M
Financing
$31.0k
ACGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACGN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ACGN$20.72M+14.37%-0.90x1.00x
DOMH$20.95M0.00%-0.98x0.26x
FBRX$21.00M-0.99%-1.30x0.49x
TPST$21.03M-0.99%-0.77x0.79x
ANGN$20.27M0.00%-1.35x0.40x

Aceragen Stock FAQ

What is Aceragen's quote symbol?

NASDAQ: ACGN) Aceragen trades on the NASDAQ under the ticker symbol ACGN. Aceragen stock quotes can also be displayed as NASDAQ: ACGN.

If you're new to stock investing, here's how to buy Aceragen stock.

What is the 52 week high and low for Aceragen (NASDAQ: ACGN)?

(NASDAQ: ACGN) Aceragen's 52-week high was $16.00, and its 52-week low was $3.66. It is currently -64.69% from its 52-week high and 54.58% from its 52-week low.

How much is Aceragen stock worth today?

(NASDAQ: ACGN) Aceragen currently has 3,667,967 outstanding shares. With Aceragen stock trading at $5.65 per share, the total value of Aceragen stock (market capitalization) is $20.72M.

Aceragen stock was originally listed at a price of $3,264.00 in Dec 31, 1997. If you had invested in Aceragen stock at $3,264.00, your return over the last 25 years would have been -99.83%, for an annualized return of -22.46% (not including any dividends or dividend reinvestments).

How much is Aceragen's stock price per share?

(NASDAQ: ACGN) Aceragen stock price per share is $5.65 today (as of Feb 3, 2023).

What is Aceragen's Market Cap?

(NASDAQ: ACGN) Aceragen's market cap is $20.72M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aceragen's market cap is calculated by multiplying ACGN's current stock price of $5.65 by ACGN's total outstanding shares of 3,667,967.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.